The EEG response to pyridoxine-IV neither identifies nor excludes pyridoxine-dependent epilepsy

Epilepsia

Volumn 51, Issue 12, 2010, Pages 2406-2411

  Bok, Levinus A ^a   Maurits, Natasha M ^b   Willemsen, Michèl A ^c   Jakobs, Cornelis ^d   Teune, Laura K ^b   Poll The, Bwee Tien ^e   De Coo, Irenaeus F ^f   Toet, Mona C ^g   Hagebeuk, Eveline E ^e   Brouwer, Oebele F ^b   Van Der Hoeven, Johannes H ^b   Sival, Deborah A ^h  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

ALDH7A1 gene mutations; Antiquitin; Electroencephalography; Neonatal seizures; Pyridoxine

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LIDOCAINE; PHENOBARBITAL; PHENYTOIN; PYRIDOXINE;

ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; COMPARATIVE STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC DISCHARGE; HUMAN; NEWBORN; PRIORITY JOURNAL; PYRIDOXINE DEPENDENT EPILEPSY; RETROSPECTIVE STUDY; THETA RHYTHM;

ALDEHYDE DEHYDROGENASE; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUNC18 PROTEINS; MUTATION; PYRIDOXINE; SPASMS, INFANTILE;

EID: 78650010093     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02747.x     Document Type: Article

References (34)

1. Baxter P. (1999) Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK. Arch Dis Child 81: 431-433.
2. Baxter P, Aicardi J. (1999) Neonatal seizures after pyridoxine use. Lancet 354: 2082-2083.
3. Baxter P. (2000) Pyridoxine dependent epilepsy: a suggestive electroclinical pattern. Arch Dis Child Fetal Neonatal Ed 83: F163.
4. Baxter P. (2001a) Pyridoxine-dependent and pyridoxine-responsive seizures. Dev Med Child Neurol 43: 416-420.
5. Baxter P. (2001b) Pyridoxine dependent and pyridoxine responsive seizures. In, Baxter P, (Ed) Vitamin responsive conditions in paediatric neurology. Mac Keith Press, London, pp. 109-165.
6. Baxter P. (2003) Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochim Biophys Acta 1647: 36-41.
7. Baxter P. (2005) Pyridoxine or pyridoxal phosphate for intractable seizures? Arch Dis Child 90: 441-442.
8. Been JV, Bok LA, Andriessen P, Renier WO. (2005) Epidemiology of pyridoxine dependent seizures in the Netherlands. Arch Dis Child 90: 1293-1296.
9. Bok LA, Struys E, Willemsen MA, Been JV, Jakobs C. (2007) Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic levels. Arch Dis Child 92: 687-689.
10. Bok LA, Been JV, Struys EA, Jakobs C, Rijper EA, Willemsen MA. (2010) Antenatal treatment in two Dutch families with pyridoxine-dependent seizures. Eur J Pediatr 169: 297-303.
11. Gallagher RC, Van Hove JL, Scharer G, Hyland K, Plecko B, Waters PJ, Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S, Salomons GS, Rosenberg EH, Struys EA, Jakobs C. (2009) Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 65: 550-556.
12. Gospe SM Jr. (1998) Current perspectives on pyridoxine-dependent seizures. J Pediatr 132: 919-923.
13. Gospe SM Jr. (2006) Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol 19: 148-153.
14. Goto T, Matsuo N, Takahashi T. (2001) CSF glutamate/GABA concentrations in pyridoxine-dependent seizures: etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control. Brain Dev 23: 24-29.
15. Haenggeli CA, Girardin E, Paunier L. (1991) Pyridoxine-dependent seizures, clinical and therapeutic aspects. Eur J Pediatr 150: 452-455.
16. Hellstrom-Westas L, Blennow G, Rosen I. (2002) Amplitude-integrated encephalography in pyridoxine-dependent seizures and pyridoxine-responsive seizures. Acta Paediatr 91: 977-980.
17. Hunt AD Jr, Stokes J Jr, McCrory WW, Stroud HH. (1954) Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 13: 140-145.
18. Kanno J, Kure S, Narisawa A, Kamada F, Takayanagi M, Yamamoto K, Hoshino H, Goto T, Takahashi T, Haginoya K, Tsuchiya S, Baumeister FA, Hasegawa Y, Aoki Y, Yamaguchi S, Matsubara Y. (2007) Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis. Mol Genet Metab 91: 384-389.
19. Lopes da Silva F. (2005) EEG analysis: theory and practice. In, Niedermeyer E, Lopes da Silva F, (Eds) Electroencephalography: basic principles, clinical applications and related fields. Lippincott Williams and Wilkins, Philadelphia, PA, pp. 1199-1232.
20. Mikati MA, Trevathan E, Krishnamoorthy KS, Lombroso CT. (1991) Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up. Electroencephalogr Clin Neurophysiol 78: 215-221.
21. Mills PB, Surtees RA, Champion MP, Beesley CE, Dalton N, Scambler PJ, Heales SJ, Briddon A, Scheimberg I, Hoffmann GF, Zschocke J, Clayton PT. (2005) Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet 14: 1077-1086.
22. Mills PB, Struys E, Jakobs C, Plecko B, Baxter P, Baumgartner M, Willemsen MA, Omran H, Tacke U, Uhlenberg B, Weschke B, Clayton PT. (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12: 307-309.
23. Naasan G, Yabroudi M, Rahi A, Mikati MA. (2009) Electroencephalographic changes in pyridoxine-dependant epilepsy: new observations. Epileptic Disord 11: 293-300.
24. Nabbout R, Soufflet C, Plouin P, Dulac O. (1999) Pyridoxine dependent epilepsy: a suggestive electroclinical pattern. Arch Dis Child Fetal Neonatal Ed 81: F125-F129.
25. Pettit RE. (1987) Pyridoxine dependency seizures: report of a case with unusual features. J Child Neurol 2: 38-40.
26. Plecko B, Paul K, Paschke E, Stoeckler-Ipsiroglu S, Struys E, Jakobs C, Hartmann H, Luecke T, Di Capua M, Korenke C, Hikel C, Reutershahn E, Freilinger M, Baumeister F, Bosch F, Erwa W. (2007) Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene. Hum Mutat 28: 19-26.
27. Rankin PM, Harrison S, Chong WK, Boyd S, Aylett SE. (2007) Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime. Dev Med Child Neurol 49: 300-305.
28. Salomons GS, Bok LA, Struys EA, Pope LL, Darmin PS, Mills PB, Clayton PT, Willemsen MA, Jakobs C. (2007) An intriguing "silent" mutation and a founder effect in antiquitin (ALDH7A1). Ann Neurol 62: 414-418.
29. Scher MS. (2003) Neonatal seizures and brain damage. Pediatr Neurol 29: 381-390.
30. Striano P, Battaglia S, Giordano L, Capovilla G, Beccaria F, Struys EA, Salomons GS, Jakobs C. (2009) Two novel ALDH7A1 (antiquitin) splicing mutations associated with pyridoxine-dependent seizures. Epilepsia 50: 933-936.
31. Teune LK, Vd Hoeven JH, Maurits NM, Bos AF, Alffenaar JW, Reijngoud DJ, Brouwer OF, Sival DA. (2007) Pyridoxine induces non-specific EEG alterations in infants with therapy resistant seizures. Seizure 16: 459-464.
32. Tsuji T, Okumura A, Ozawa H, Ito M, Watanabe K. (2007) Current treatment of West syndrome in Japan. J Child Neurol 22: 560-564.
33. Wang HS, Kuo MF, Chou ML, Hung PC, Lin KL, Hsieh MY, Chang MY. (2005) Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy. Arch Dis Child 90: 512-515.
34. Whittington MA, Traub RD, Kopell N, Ermentrout B, Buhl EH. (2000) Inhibition-based rhythms: experimental and mathematical observations on network dynamics. Int J Psychophysiol 38: 315-336.